Eledon Pharmaceuticals, Inc. (ELDN) › Shares OutstandingEledon Pharmaceuticals, Inc. (ELDN) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 493.3K2014: 22.38M2015: 22.60M2016: 394.3K2017: 7.11M2018: 9.42M2019: 720.4K2020: 15.16M2021: 14.31M2022: 13.78M2023: 24.21M2024: 59.79M2025: 75.43M75.43M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202575.43M+26.2%202459.79M+146.9%202324.21M+75.8%202213.78M-3.7%202114.31M-5.6%202015.16M+2004.4%2019720.4K-92.4%20189.42M+32.5%20177.11M+1703.3%2016394.3K-98.3%201522.60M+1.0%201422.38M+4437.3%2013493.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share